PDGFRB Cancer Research Results

PDGFRB, Platelet-derived growth factor receptor beta: Click to Expand ⟱
Source:
Type:

PDGFRB is a true druggable receptor tyrosine kinase with relevance to tumor stroma, angiogenesis, pericytes, fibrosis, BBB integrity, and AD vascular dysfunction.

Field Suggested Entry
Target PDGFRB / PDGFR-β
Full Name Platelet-derived growth factor receptor beta
Target Class Receptor tyrosine kinase
Main Ligands PDGF-BB, PDGF-DD
Primary Biology Pericyte recruitment, vascular maturation, fibroblast activation, stromal remodeling, cell migration, proliferation, BBB maintenance
Cancer Relevance High: tumor stroma, angiogenesis, pericytes, CAFs, invasion, metastasis, therapy resistance
AD Relevance Medium-high: brain pericytes, blood-brain barrier integrity, neurovascular dysfunction, soluble PDGFRβ as a pericyte injury marker
Therapeutic Direction Context-dependent. In cancer, inhibition or stromal normalization may be useful. In AD, preservation/restoration of PDGFRβ signaling is likely protective.


Scientific Papers found: Click to Expand⟱
6466- 1,8-Cin,    Transcriptome Analysis Reveals the Anti-Tumor Mechanism of Eucalyptol Treatment on Neuroblastoma Cell Line SH-SY5Y
- in-vitro, neuroblastoma, SH-SY5Y
AntiTum↑, Previous studies have shown that eucalyptol has anti-tumor effects on leukemia and colon cancer.
TumCCA↑, GO function analysis showed that positive regulation of cell cycle was down-regulated in biological processes.
PDGFRB↓, fig 2
Myc↓, BAD3, TBX3 and APC were up-regulated genes, at the same time, oncogenes LEF1, PDGFRB, and MYC were down-regulated genes
LEF1↓,
BAD↑,
APC↑,
TBX3↑,

7393- Amla,    Emblica officinalis extract induces autophagy and inhibits human ovarian cancer cell proliferation, angiogenesis, growth of mouse xenograft tumors
- vitro+vivo, Ovarian, OVCAR-3 - in-vitro, Ovarian, SW626
TumCP↓, Amla extract (AE) has anti-proliferative effects on OC cells under both in vitro and in vivo conditions.
Beclin-1↑, AE did not induce apoptotic cell death, but did significantly increase the expression of the autophagic proteins beclin1 and LC3B-II under in vitro conditions.
LC3B-II↑,
Hif1a↓, AE also significantly reduced the expression of several angiogenic genes, including hypoxia-inducible factor 1α (HIF-1α) in OVCAR3 cells.
Dose↝, cell proliferation was significantly inhibited at AE concentrations ranging from 300–1000 µg/ml
TumAuto↑, AE induces autophagy in OVCAR3 and SW626 cells
angioG↓, AE inhibits angiogenesis-related genes in OVCAR3 cells
COL4A3↓, The expression of COL4A3, CXCL6, ECGF1, EFNB2, FGF2, IL1β, PDGFB, TNFRSF12A and HIF-1α were reduced to less than 40% of control levels (Figure 5D), with Hif-1α being inhibited to the greatest extent.
CXCL6/GCP-2↓,
TYMP/ECGF1↓,
IL1β↓,
PDGFRB↓,
ChemoSen↑, AE with cisplatin synergistically reduced cell proliferation in OVCAR3 cells
Dose↝, mice were fed orally with 10% sucrose (control) or 10% sucrose with AE (100 mg/kg body wt.) daily.


Showing Research Papers: 1 to 2 of 2

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

COL4A3↓, 1,   CXCL6/GCP-2↓, 1,   TYMP/ECGF1↓, 1,  

Cell Death(tgid=5) ⓘ

BAD↑, 1,   Myc↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1↑, 1,   LC3B-II↑, 1,   TumAuto↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

TBX3↑, 1,   TumCCA↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

PDGFRB↓, 2,  

Migration(tgid=13) ⓘ

APC↑, 1,   LEF1↓, 1,   TumCP↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,   Hif1a↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

IL1β↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ChemoSen↑, 1,   Dose↝, 2,  

Clinical Biomarkers(tgid=22) ⓘ

Myc↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiTum↑, 1,  
Total Targets: 21

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: PDGFRB, Platelet-derived growth factor receptor beta
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1495  State#:%  Dir#:1
  wNotes=on  sortOrder:rid,rpid

 

Home Page